180 related articles for article (PubMed ID: 35401543)
1. Cannabidiol and SARS-CoV-2 Infection.
Vallée A
Front Immunol; 2022; 13():870787. PubMed ID: 35401543
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment.
Vallée A; Lecarpentier Y; Vallée JN
Front Immunol; 2021; 12():666693. PubMed ID: 33927728
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line.
Corpetti C; Del Re A; Seguella L; Palenca I; Rurgo S; De Conno B; Pesce M; Sarnelli G; Esposito G
Phytother Res; 2021 Dec; 35(12):6893-6903. PubMed ID: 34643000
[TBL] [Abstract][Full Text] [Related]
4. In search of preventive strategies: novel high-CBD
Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
[TBL] [Abstract][Full Text] [Related]
5. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.
Kar P; Saleh-E-In MM; Jaishee N; Anandraj A; Kormuth E; Vellingiri B; Angione C; Rahman PKSM; Pillay S; Sen A; Naidoo D; Roy A; Choi YE
J Cell Biochem; 2022 May; 123(5):964-986. PubMed ID: 35342986
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review.
Zielińska A; Eder P; Karczewski J; Szalata M; Hryhorowicz S; Wielgus K; Szalata M; Dobrowolska A; Atanasov AG; Słomski R; Souto EB
Front Immunol; 2023; 14():1147991. PubMed ID: 37033914
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
8. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.
Malinowska B; Baranowska-Kuczko M; Kicman A; Schlicker E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671463
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
Viruses; 2022 May; 14(5):. PubMed ID: 35632769
[TBL] [Abstract][Full Text] [Related]
10. Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants.
Dehghani J; Movafeghi A; Mathieu-Rivet E; Mati-Baouche N; Calbo S; Lerouge P; Bardor M
Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354980
[TBL] [Abstract][Full Text] [Related]
11. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
[No Abstract] [Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
14. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
[TBL] [Abstract][Full Text] [Related]
15. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19.
Marques GVL; Marques DPA; Clarindo FA; Avendaño-Villarreal JA; Guerra FS; Fernandes PD; Dos Santos EN; Gusevskaya EV; Kohlhoff M; Moreira FA; Andrade LAF; Fonseca FGD; Dos-Reis JGAC; Oliveira RB
Eur J Med Chem; 2023 Nov; 260():115760. PubMed ID: 37657273
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
Ohishi T; Hishiki T; Baig MS; Rajpoot S; Saqib U; Takasaki T; Hara Y
PLoS One; 2022; 17(7):e0271112. PubMed ID: 35830431
[TBL] [Abstract][Full Text] [Related]
19. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
20. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
